Breast Case Share | Ductal Carcinoma In Situ: Early Detection and Management

Release time:

2024/10/31

We present a significant case of early breast cancer discovered through advanced ultrasound imaging technology. A 53-year-old woman, who regularly underwent handheld ultrasound breast examinations, volunteered to use our 3D Automated Breast Ultrasound System, Cygnus, during its trial in the health examination department of the hospital.

During the examination, a lesion measuring 13.2 mm x 10.4 mm x 10.7 mm was detected, located just 4 mm from the nipple. Notably, a pronounced "Retraction Phenomenon" was observed on the coronal view, an important ultrasound feature for breast cancer diagnosis—particularly sensitive for invasive breast cancer. This area is commonly missed during traditional examinations due to its proximity to the nipple. The surrounding tissue presents radial retraction, providing critical insights into the lesion’s characteristics.

Subsequent mammography found microcalcifications in this tiny lesion. Finally, this lesion, which was not feasible for biopsy, was revealed as ductal carcinoma in situ (DCIS) after surgical excision.

The “Retraction Phenomenon” is a vital ultrasound indicator for breast cancer diagnosis, especially for mass-type lesions. The unique coronal plane reconstruction capability of the Cygnus system enables ultrasound physicians to visualize the infiltration information of the mass at different depths, offering diagnostic information that conventional handheld ultrasound may not capture.

 

About Cygnus

Focus & Fusion Healthcare's Cygnus system combines the advantages of 3D automated breast ultrasound and handheld ultrasound into one comprehensive platform. This innovative system is able to cover almost all the applications of medical ultrasound including screening, diagnosis, monitoring, and treatment, which contributes to full cycle management of breast diseases.

 

Breast Cancer Awareness Month

October is Breast Cancer Awareness Month, a time to emphasize the importance of early detection and education. In 2024, more than 360,000 people will be diagnosed with breast cancer. But there is hope. Advancements in early detection methods continue to increase the chances of survival. When breast cancer is caught in its earliest, localized stages, the 5-year relative survival rate can reach 99%. Therefore, the earlier we act, the bigger our impact.

 

Conclusion

This case exemplifies the critical role that the advanced imaging technology plays in early breast cancer detection. The Cygnus system empowers healthcare professionals with the tools needed for precise diagnosis and full-cycle management of breast diseases, ultimately enhancing women’s health.

For more information about the Cygnus system and how it can benefit breast cancer detection and management, please visit our website at https://www.focus-fusion.com/Cygnus_70.html.